Jeff Aronin’s Quest to Improving Lives

Since 2010, Jeff Aronin has been the chairman and chief executive officer of Paragon Pharmaceuticals, an international healthcare development company as well as a biopharmaceutical investment firm. He has also been managing several other Paragon portfolio companies including Harmony Biosciences and Castle Creek Pharmaceuticals.

Before his employment in Paragon pharmaceuticals and between the years 2000 and 2009, Mr. Jeff was the president and the CEO of Ovation Pharmaceuticals Inc. This too is a biopharmaceutical company that he founded in 2000. After the acquisition of his company by Lundbeck, Inc., Aronin found a similar position he had held in Ovation Pharmaceuticals in Paragon. This was however not before he served as the president and CEO of Lundbeck, Inc. until the integration of Ovation Pharmaceuticals.

 

Having served in the top management level in at least three companies in the pharmaceuticals industry, Jeff Aronin has diverse experience and great skills which include business and strategic development, finance as well as brand marketing. He has worked with three global pharmaceutical industries, which makes his day-to-day management of a global corporation easy and effective. Jeffrey also has great experience in the structuring and execution of strategic corporate connections, such as acquisitions and mergers.

 

Today, Jeff is among the most influential, successful and innovative leaders in the bioscience industry and he is admired by many people. With over 20 years of experience in global biotech development and healthcare innovations, he can be the best entrepreneur, mentor and innovator the world has at the moment. He has handled several complex science, drug development and rare diseases in the past, which have made him an expert in the field.

 

He does not work alone though; he has great passion in working together as a team. Throughout his career, he has created great teams of talented individuals, with science and business qualifications to work as researches for drugs and therapies. All his teams have always shown a good track record of performance and have been able to bring new medicines to the market. This has enabled Jeff Aronin to accomplish all the goals he sets in improving the lives of patients, who are sometimes overlooked.

 

The contributions of Jeff Aronin in Pharmaceuticals

Health is a significant factor in improving people’s lives. The number of illnesses without adequate treatments are becoming the most significant challenges facing medical professionals today. This is the reason behind Jeff Aronin establishing Paragon Bioscience. For more than two decades, Jeff has been at the top of the game in biotech and health. As the CEO and Chairman of Paragon Bioscience, Jeff Aronin has applied his entrepreneurial energy and expertise in the industry to build an incubator and a leading investor of biotech companies. His passion for helping patients is what drove him for science. Having seen how magical the pharmaceuticals were doing, Jeff Aronin founded Ovation Pharmaceuticals Inc. in the year 2000. The success of his company was deeply rooted in his ability to understand the need of a patient, recognizing promising science, and focusing his team on getting the medicine approved.

 

Jeff Aronin has been on the front line addressing the unfulfilled needs of those suffering from the rare diseases. His scientific visionary and entrepreneurial work are some of the things that have largely contributed to a dozen of technologies and new medicines being developed and approved. Jeff has been privileged to serve as a chairman in some life science companies that include, Castle Creek Pharmaceuticals, Harmony Biosciences, and Paragon Pharmaceuticals. His level of success can be matched to a limited number of those operating in the same industry. Jeff Aronin is very kind to share his perspective with those seeking growth in healthcare.

 

At paragon Bioscience, the cause of a given condition or disease is first identified to get a better outcome. The next thing that the team does is to determine the science with the best treatment. Development and research of medicine are one of the risky businesses in existence as it can lead to loss of lives. Many of the procedures might seem promising during the trial phase of the research only to end up failing. Despite this, Jeff Aronin and his team remain focused on developing medicines and illnesses that need treatment most. By clinging to its core values and missions, Jeff believes that the company will realize its goals by applying these innovative treatments.